Sandoz launches generic Emend capsules

PRINCETON, N.J. — Sandoz on Wednesday announced the launch of its generic of Emend (aprepitant) capsules. The drug is indicated to prevent nausea and vomiting caused by certain chemotherapy medicines in patients ages 12 years and older, as well as to prevent nausea and vomiting after surgery. 
“Sandoz is the first company to offer a generic of Emend capsules, which demonstrates our passion for bringing high-quality generic medicines to patients and healthcare professionals,” Sandoz president Peter Goldschmidt said. 
The drug will be available in 40-, 80- and 125-mg dosage strengths. It had U.S. sales of about $62 million for the 12 months ended October 2016, according to QuintilesIMS data. 
Login or Register to post a comment.